C
CDXS
Codexis Inc
1.980
+0.090+4.76%After Hours: 1.950 -0.030 -1.52%17:44 04/07 EDT
OPEN/PREV CLOSE2.010/1.980
TODAY RANGE2.010-2.230
VOL2.21M
MARKET CAP200.82M
52 WEEK RANGE0.9583-3.870
AVG VOL (3M)2.30M
% TURNOVER2.43%
TURNOVER--
P/E (TTM)-4.3797
% RANGE11.11%
EPS(TTM)-0.5046
P/E(FORWARD)-4.9111
P/B3.957
BVPS0.5585
DIVIDEND--
P/S2.841
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP185.09M
SHARES OUTSTANDING90.87M
NEXT EARNINGS05/12-05/18
FREE FLOAT83.75M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·04/01 18:35
Codexis (CDXS) Gets a Buy from Jefferies
Simply Wall St·03/15 15:13
Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue Guidance - Has The Bull Case Changed?
Simply Wall St·03/14 13:29
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement
TipRanks·03/13 08:15
Craig-Hallum Sticks to Its Buy Rating for Codexis (CDXS)
TipRanks·03/13 00:03
Codexis Earnings Call: ECOsynthesis Momentum Amid Risks
Simply Wall St·03/12 22:34
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative
Seeking Alpha·03/12 17:33
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform
Benzinga·03/12 17:05
12 Health Care Stocks Moving In Thursday's Intraday Session
NASDAQ·03/12 16:14
Thursday Sector Leaders: Oil & Gas Refining & Marketing, Chemicals
Benzinga·03/12 13:49
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall
Benzinga·03/12 12:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Seeking Alpha·03/12 11:39
Codexis rises after Q4 beat, strong outlook
NASDAQ·03/12 10:56
Codexis Jumps On Q4 Results, Expects 2-8% Revenue Growth In FY'26
Same Industry
Name/Symbol
Change%
Price